Evidence map›Paper›PMID 30536619›Full record

ArticleJournal of cellular physiology2019

microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.

Fang Wang, Aihong Mao, Jinzhou Tang, Qianjing Zhang, Junfang Yan, Yupei Wang, Cuixia Di, Lu Gan, Chao Sun, Hong Zhang

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Advances in Prostate Cancer Biomarkers and Probes.Cyborg and bionic systems (Washington, D.C.) · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. [miR-16-5p regulates apoptosis and migration of drug-resistant breast cancer cells by targeting YWHAQ].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  16. Article
  17. miR-16-5p Is a Novel Mediator of Venous Smooth Muscle Phenotypic Switching.Journal of cardiovascular translational research · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fang WangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Aihong MaoInstitute of Gansu Medical Science Research, Lanzhou, People's Republic of China.
Jinzhou TangSchool of Life Science, Lanzhou University, Lanzhou, People's Republic of China.
Qianjing ZhangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Junfang YanInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Yupei WangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Cuixia DiInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Lu GanInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Chao SunInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
Hong ZhangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.ORCID 0000-0002-6039-0640
Chinese Academy of Sciences · CNGansu Institute of Political Science and Law · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (CaP) is the second most common cancer in men worldwide in 2012, and radiation therapy is one of the most common definitive treatment options for localized CaP. However, radioresistance is a major challenge for the current radiotherapy, accumulating evidences suggest microRNAs (miRNAs), as an important regulator in cellular ionizing radiation (IR) responses, are closely correlated with radiosensitivity in many cancers. Here, we identified microRNA-16-5p(miR-16-5p) is significantly upregulated in CaP LNCaP cells following IR and can enhance radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway. To identify the expression profile of miRNAs in CaP cells exposed to IR, we performed human miRNA probe hybridization chip analysis and miR-16-5p was found to be significantly overexpressed in all treatment groups that irradiated with different doses of X-rays and heavy ions (

Indexed as

Cell Cycle CheckpointsCell Line, TumorCyclin D1Cyclin EE2F1 Transcription FactorGene Expression Regulation, NeoplasticHumansMaleMicroRNAsOncogene ProteinsProstatic NeoplasmsRadiation ToleranceRetinoblastoma ProteinSignal TransductionCCND1 protein, humanCCNE1 protein, humanCyclin D1Cyclin EE2F1 protein, humanE2F1 Transcription FactorMicroRNAsMIRN16 microRNA, humanOncogene ProteinsRetinoblastoma Proteincell cycle arrestmiR-16-5pprostate cancerradiosensitivity

Identifiers

PMID30536619
PMCPMC13483218
OpenAlexW2904905985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.